Back
Smith & Nephew plc Vs. Axsome Therapeutics, Inc. Industry Stock Comparison
Sell
35
SNNUF
Smith & Nephew plc
Last Price:
$16.50
Seasonality Move:
-3.71%
Buy
75
AXSM
Axsome Therapeutics, Inc.
Last Price:
$175.62
Seasonality Move:
22.61%
Sell
35
Smith & Nephew plc (SNNUF)
is a Sell
Is Smith & Nephew plc a Buy, Sell or Hold?
-
The current Smith & Nephew plc [SNNUF] share price is $16.50. The Score for SNNUF is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
SNNUF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Axsome Therapeutics, Inc. (AXSM)
is a Buy
Is Axsome Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Axsome Therapeutics, Inc. [AXSM] share price is $182.64. The Score for AXSM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
AXSM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SNNUF Stock Price Chart
What is Smith & Nephew plc's stock price today?
-
The Smith & Nephew plc share price today is $16.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNNUF is experiencing slight buying pressure.
AXSM Stock Price Chart
What is Axsome Therapeutics, Inc.'s stock price today?
-
The Axsome Therapeutics, Inc. share price today is $182.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing buying pressure, which is a positive indicator for future bullish movement.
SNNUF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.43 | Buy |
| Relative Strength Index (14 RSI): | 70.87 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.68 - 16.06) | Buy |
| Bollinger Bands (100): | (15.73 - 17.89) | Sell |
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.73 | Buy |
| Relative Strength Index (14 RSI): | 79.74 | Buy |
| Chaikin Money Flow: | 2638953 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (143.49 - 157.75) | Buy |
| Bollinger Bands (100): | (116.98 - 146.48) | Buy |
SNNUF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.97 | Buy |
| 20-day SMA: | 15.24 | Buy |
| 50-day SMA: | 15.96 | Buy |
| 200-day SMA: | 15.64 | Buy |
| 8-day EMA: | 14.73 | Buy |
| 20-day EMA: | 10.06 | Buy |
| 50-day EMA: | 5.23 | Buy |
| 200-day EMA: | 1.51 | Buy |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 156.17 | Buy |
| 20-day SMA: | 151.07 | Buy |
| 50-day SMA: | 144.32 | Buy |
| 200-day SMA: | 119.69 | Buy |
| 8-day EMA: | 157.9 | Buy |
| 20-day EMA: | 152.42 | Buy |
| 50-day EMA: | 144.44 | Buy |
| 200-day EMA: | 123.72 | Buy |
Smith & Nephew plc Earnings Growth & SNNUF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Axsome Therapeutics, Inc. Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.16 per share, and an increase next year of $5.95 per share.
Smith & Nephew plc Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axsome Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||